Home » AZ Receives European Commission’s OK for COPD Treatment
AZ Receives European Commission’s OK for COPD Treatment
The European Commission has approved AstraZeneca’s Bevespi Aerosphere, a long-term chronic obstructive pulmonary disease (COPD) treatment that is administered via a pressurized metered-dose inhaler.
The twice daily, fixed-dose device combines glycopyrronium and formoterol fumarate.
AZ’s treatment is not indicated for the relief of acute bronchospasm or for treating asthma.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct